First-in-man and DES trials

Session comprising selected EuroPCR 2016 late-breaking trial submissions

Presentations available when logged in:

  • Fantom sirolimus-eluting BRS
  • Safety and clinical performance of the drug-eluting absorbable metal scaffold in the treatment of subjects with de novo lesions in native coronary...
  • One-year results of first-in-man trial randomising the sirolimus-eluting polylactide scaffold and the everolimus-eluting polylactide scaffold
  • Primary endpoint results from the NIREUS trial. A prospective randomised trial comparing the novel ridaforolimus-eluting BioNIR stent to the zotaro...
  • In vivo healing response to bioresorbable, abluminal polymer everolimus-eluting stents vs. durable, conformal polymer zotarolimus-eluting stents. T...
  • Angiographic outcomes of Orsiro biodegradable polymer sirolimus-eluting stents and Resolute Integrity durable polymer zotarolimus-eluting stents: r...
  • Nine-month clinical and angiographic outcomes after coronary stenting of small vessels in Japanese population using 2.25mm diameter sirolimus-eluti...